Prof. Dr. GÜZİDE NEVSUN İNANÇ

Yayın Ağı

Makaleler 71

1. Incident rheumatoid arthritis in patients living in Turkey and in Denmark: a comparative clinical, genetic, and serological study

Rasmussen C., Can G., Steffensen R., Kenar Artin G., Tuğsal H., Solmaz D., et al.

Scandinavian Journal of Rheumatology , cilt.54, sa.3, ss.158-165, 2025 (SCI-Expanded, Scopus)

2. Efficacy and Safety of CT-P13 as First- and Second-Line Treatment in Patients with Ankylosing Spondylitis

Uslu S., Gülle S., ŞEN G., ÇAPAR S., Senel S., DALKILIÇ H. E., et al.

Journal of Clinical Medicine , cilt.13, sa.23, 2024 (SCI-Expanded, Scopus)

3. Psychological resilience in patients with primary Sjögren's syndrome: effect of involvement of major salivary and lacrimal glands

Sevimli E., GÜNAY S., Aliyeva A., Aksoy B., Fortune F., İNANÇ G. N., et al.

European Journal of Oral Sciences , cilt.132, sa.6, 2024 (SCI-Expanded)

4. Assessing safety and efficacy of TNFi treatment in late onset ankylosing spondylitis: a TURKBIO registry study

Uslu S., Gulle S., Sen G., Cefle A., Yilmaz S., Kocaer S. B., et al.

Scientific Reports , cilt.14, sa.1, 2024 (SCI-Expanded, Scopus)

5. Biological treatment in elderly and young patients with ankylosing spondylitis: TURKBIO real-life data results

USLU S., GÜLLE S., URAK Ö., ŞEN G., DALKILIÇ E., ŞENEL S., et al.

Archives of Rheumatology , cilt.39, sa.2, ss.232-241, 2024 (SCI-Expanded)

6. Evaluation of discontinuation for adverse events of JAK inhibitors and bDMARDs in an international collaboration of rheumatoid arthritis registers (the ‘JAK-pot’ study)

Aymon R., Mongin D., Bergstra S. A., Choquette D., Codreanu C., De Cock D., et al.

Annals of the Rheumatic Diseases , cilt.83, sa.4, ss.421-428, 2023 (SCI-Expanded, Scopus)

7. Unintentional Monotherapy in Rheumatoid Arthritis Patients Receiving Tofacitinib and Drug Survival Rate of Tofacitinib

İNANÇ G. N., Abacar K. Y., ÖZTÜRK M. A., TUFAN A., Karadeniz H., SARI İ., et al.

Journal of Clinical Rheumatology , cilt.29, sa.8, ss.365-369, 2023 (SCI-Expanded)

8. Hypogammaglobulinemia and severe infection risk in patients with autoimmune diseases during rituximab treatment Otoimmün hastalığı olan hastalarda rituksimab tedavisi sırasında hipogamaglobulinemi ve enfeksiyon riski

Kaymaz Tahra S., ALİBAZ ÖNER F., KAPLAN T., Yalçınkaya Y., İNANÇ G. N., ATAGÜNDÜZ M. P., et al.

Journal of Turkish Society For Rheumatology , cilt.15, sa.3, ss.154-161, 2023 (Scopus)

9. Does decision tree analysis predict oral ulcer activity-related factors in patients with Behçet's syndrome?

ÇANDERELİ Z. Ö., Arslan T., Özdamar Ö., Yay M., Karaçayli Ü., ŞİŞMAN KİTAPÇI N., et al.

Clinical and experimental rheumatology , cilt.41, sa.10, ss.2078-2086, 2023 (SCI-Expanded, Scopus)

10. Paraffin stimulation might not be necessary for the collection of saliva: effect on the rate and cellular distribution in primary Sjögren's syndrome.

Abacar K. Y., Aydin-Tatli I., Çolakoğlu Ş., Inanc N., Mumcu G., Atagündüz P.

Clinical and experimental rheumatology , cilt.41, ss.18-19, 2023 (SCI-Expanded)

11. Treatment of systemic sclerosis-associated digital ulcers: recommendations of the Turkish Society for Rheumatology

TEMİZ KARADAĞ D., Yalcinkaya Y., AKDOĞAN A., Avanoglu A., Bes C., BİRLİK A. M., et al.

Clinical and experimental rheumatology , cilt.41, sa.8, ss.1679-1687, 2023 (SCI-Expanded)

12. Efficacy of certolizumab pegol across baseline rheumatoid factor subgroups in patients with rheumatoid arthritis: Post-hoc analysis of clinical trials

Tanaka Y., Takeuchi T., Haaland D., Hall S., Inanc N., Li Z., et al.

INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES , cilt.26, sa.7, ss.1248-1259, 2023 (SCI-Expanded)

13. Mortality risk factors in primary Sjögren syndrome: a real-world, retrospective, cohort study

Brito-Zerón P., Flores-Chávez A., Horváth I. F., Rasmussen A., Li X., Olsson P., et al.

eClinicalMedicine , cilt.61, 2023 (SCI-Expanded)

14. The provisional OMERACT ultrasonography score for giant cell arteritis

Dejaco C., Ponte C., Monti S., Rozza D., Scirè C. A., Terslev L., et al.

Annals of the Rheumatic Diseases , cilt.82, sa.4, ss.556-564, 2023 (SCI-Expanded)

15. RE: Risk of HBV Reactivation in HBsAg Negative and AntiHBc IgG Positive Patients Receiving Biologic Therapy

Ergenç İ., KANİ H. T., KARABACAK M., CÖMERT ÖZER E., Mehdiyev S., Jafarov F., et al.

The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology , cilt.34, sa.3, ss.310, 2023 (SCI-Expanded)

16. After JAK inhibitor failure: to cycle or to switch, that is the question - data from the JAK-pot collaboration of registries

Pombo-Suarez M., Sanchez-Piedra C., Gomez-Reino J., Lauper K., Mongin D., Iannone F., et al.

ANNALS OF THE RHEUMATIC DISEASES , cilt.82, sa.2, ss.175-181, 2023 (SCI-Expanded)

17. A national, multicenter, retrospective study evaluating retention rate and efficacy of tocilizumab treatment in patients with active rheumatoid arthritis who had an inadequate response to csDMARDs and/or TNF inhibitors

İNANÇ G. N., TERZİOĞLU M. E., Karabulut Y., Yilmaz Z., Tarhan E. F., Enecik M. E., et al.

Turkish Journal of Medical Sciences , cilt.53, sa.3, ss.731-743, 2023 (SCI-Expanded)

18. The impact of smoking on response to tumor necrosis factor-α inhibitor treatment in patients with ankylosing spondylitis

Yarkan Tuğsal H., KENAR ARTIN G., CAN G., ÇAPAR S., Zengin B., Akar S., et al.

Turkish Journal of Medical Sciences , cilt.53, sa.4, ss.970-978, 2023 (SCI-Expanded)

19. Body mass index does not affect response of rituximab in patients with rheumatoid arthritis: results from the TURKBİO registry

Karataş A., Pişkin Sağir R., Koca S. S., DALKILIÇ H. E., CAN G., PEHLİVAN Y., et al.

Turkish Journal of Medical Sciences , cilt.53, sa.5, ss.1321-1329, 2023 (SCI-Expanded)

20. VALIDITY OF THE NOVEL OMERACT ULTRASOUND SCORING SYSTEM FOR SALIVARY GLANDS TARGET LESIONS IN SJOGREN'S SYNDROME

İNANÇ G. N., Jousse-Joulin S., Abacar K. Y., ÇİMŞİT C., ÇİMŞİT N. Ç., D'Agostino M., et al.

CLINICAL AND EXPERIMENTAL RHEUMATOLOGY , cilt.40, sa.12, ss.60, 2022 (SCI-Expanded)

21. Safety and efficacy of SARS-CoV-2 vaccination in 1237 patients with primary Sjögren syndrome.

Inanc N., Kostov B., Priori R., Flores-Chavez A., Carubbi F., Szántó A., et al.

Clinical and experimental rheumatology , cilt.40, sa.12, ss.2290-2297, 2022 (SCI-Expanded)

22. Multimodal Approach of Isolated Pulmonary Vasculitis: A Single-Institution Experience

Yanartaş M., Karakoç A. Z., Zengin A., Taş S., Olgun Yildizeli Ş., Mutlu B. L., et al.

ANNALS OF THORACIC SURGERY , cilt.114, sa.4, ss.1253-1261, 2022 (SCI-Expanded, Scopus)

23. Development of a new ultrasound scoring system to evaluate glandular inflammation in Sjögren's syndrome: an OMERACT reliability exercise

Hočevar A., Bruyn G. A., Terslev L., De Agustin J. J., MacCarter D., Chrysidis S., et al.

Rheumatology (Oxford, England) , cilt.61, sa.8, ss.3341-3350, 2022 (SCI-Expanded)

24. Effectiveness of TNF-inhibitors, abatacept, IL6-inhibitors and JAK-inhibitors in 31 846 patients with rheumatoid arthritis in 19 registers from the 'JAK-pot' collaboration

Lauper K., Ludici M., Mongin D., Bergstra S. A., Choquette D., Codreanu C., et al.

ANNALS OF THE RHEUMATIC DISEASES , cilt.81, sa.10, ss.1358-1366, 2022 (SCI-Expanded)

25. Pulmonary Endarterectomy in Patients with Antiphospholipid Syndrome-Associated Chronic Thromboembolic Pulmonary Hypertension.

Taş S., Antal A., Durusoy A. F., Yanartaş M., Yıldız K., Olgun Yıldızeli Ş., et al.

Anatolian journal of cardiology , cilt.26, sa.5, ss.394-400, 2022 (SCI-Expanded, Scopus, TRDizin)

26. The assessment of presenteeism and activity impairment in Behçet's syndrome and recurrent aphthous stomatitis: a multicentre study.

Karacayli U., Adesanya A., Aksoy A., Belem J. M. F. M., Cardin N. B., Sarı F. B., et al.

Rheumatology (Oxford, England) , cilt.61, sa.4, ss.1538-1547, 2022 (SCI-Expanded, Scopus)

27. Balloon Pulmonary Angioplasty in Patients With Inoperable or Recurrent/Residual Chronic Thromboembolic Pulmonary Hypertension: A Single-Centre Initial Experience

Atas H., Mutlu B., Akaslan D., Kocakaya D., Kanar B., Inanc N., et al.

HEART LUNG AND CIRCULATION , cilt.31, sa.4, ss.520-529, 2022 (SCI-Expanded)

28. A real-life analysis of patients with rheumatologic diseases on biological treatments: Data from TURKBIO Registry.

Önen F., Can G., Çapar S., Dalkılıç E., Pehlivan Y., Şenel S., et al.

European journal of rheumatology , cilt.9, sa.2, ss.82-87, 2022 (ESCI, TRDizin)

29. Outcome of solid and cavitary pulmonary nodules in rheumatoid arthritis patients— case series

AKSOY A., KOCAKAYA D., Yalçinkaya Y., BOZKURTLAR E., KARAKURT S., Eryüksel E., et al.

Turkish Journal of Medical Sciences , cilt.52, sa.5, ss.1713-1720, 2022 (SCI-Expanded)

30. Evaluation of rheumatoid arthritis and connective tissue disease-related interstitial lung disease with pulmonary physiologic test, HRCT, and patient-based measures of dyspnea and functional disability

TOPÇU A., Mursaloglu H. H., Yalcinkaya Y., KARAKURT S., Yagiz B., ALACA TOPÇU Z., et al.

CLINICAL RHEUMATOLOGY , cilt.40, ss.3797-3805, 2021 (SCI-Expanded)

31. Novel and known periodontal pathogens residing in gingival crevicular fluid are associated with rheumatoid arthritis

Manoil D., Bostanci N., MUMCU G., Inanc N., Can M., Direskeneli H., et al.

JOURNAL OF PERIODONTOLOGY , cilt.92, sa.3, ss.359-370, 2021 (SCI-Expanded, Scopus)

32. Elevated serum TREM-1 is associated with periodontitis and disease activity in rheumatoid arthritis.

Inanc N., Mumcu G., Can M., Yay M., Silbereisen A., Manoil D., et al.

Scientific reports , cilt.11, sa.1, ss.2888, 2021 (SCI-Expanded, Scopus)

33. Post-COVID-19 syndrome in patients with primary Sjogren's syndrome after acute SARS-CoV-2 infection

Brito-Zeron P., Acar-Denizli N., Romao V. C., Armagan B., Seror R., Carubbi F., et al.

CLINICAL AND EXPERIMENTAL RHEUMATOLOGY , cilt.39, sa.6, 2021 (SCI-Expanded) Sürdürülebilir Kalkınma

34. Influence of the age at diagnosis in the disease expression of primary Sjögren syndrome. Analysis of 12,753 patients from the Sjögren Big Data Consortium.

Retamozo S., Acar-Denizli N., Horváth I. F., Ng W., Rasmussen A., Dong X., et al.

Clinical and experimental rheumatology , cilt.39, sa.6, ss.166-174, 2021 (SCI-Expanded)

35. Moderation analysis exploring associations between age and mucocutaneous activity in Behçet's syndrome: A multicenter study from Turkey.

MUMCU G., Yay M., Karacayli U., Aksoy A., Tas M. N., Armagan B., et al.

The Journal of dermatology , cilt.47, sa.12, ss.1403-1410, 2020 (SCI-Expanded, Scopus)

36. EULAR/eumusc.net standards of care for rheumatoid arthritis: cross-sectional analyses of importance, level of implementation and care gaps experienced by patients and rheumatologists across 35 European countries

Meisters R., Putrik P., Ramiro S., Hifinger M., Keszei A. P., van Eijk-Hustings Y., et al.

ANNALS OF THE RHEUMATIC DISEASES , cilt.79, sa.11, ss.1423-1431, 2020 (SCI-Expanded, Scopus)

37. Behçet Hastalığının Yönetiminde Oral Sağlık ile İlişkili Klinik Parametreleri ve Hasta Kaynaklı ÇıktılarıNasıl Değerlendirmeliyiz?

MUMCU G., KARAÇAYLI Ü., İNANÇ G. N., ERGÜN T., ATALAY T., DİRESKENELİ R. H.

Türkiye Klinikleri Diş Hekimliği Bilimleri Dergisi , cilt.26, sa.2, ss.268-275, 2020 (Hakemli Dergi)

38. Predictive factors for work-day loss in Behçet's syndrome: A multi-center study.

MUMCU G., Yay M., AKSOY A., Tas M. N., ARMAĞAN B., Sari A., et al.

International journal of rheumatic diseases , cilt.23, sa.2, ss.240-246, 2020 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

39. Predictors and the optimal duration of sustained remission in rheumatoid arthritis

Yilmaz-Oner S., Gazel U., Can M., ATAGÜNDÜZ M. P., DİRESKENELİ R. H., Inanc N.

CLINICAL RHEUMATOLOGY , cilt.38, sa.11, ss.3033-3039, 2019 (SCI-Expanded, Scopus)

40. Does illness perception associate with disease symptoms in Behçet's disease?

MUMCU G., YAĞAR F., Alibaz-Oner F., İNANÇ G. N., DİRESKENELİ R. H., ERGÜN T.

Internal and emergency medicine , cilt.14, sa.5, ss.691-697, 2019 (SCI-Expanded, Scopus)

41. Advanced Glycation End Products, a Potential Link between Psoriasis and Cardiovascular Disease: A Case-control Study.

Ergun T., Yazici V., YAVUZ D., Seckin-Gencosmanoglu D., Ozen G., SALMAN A., et al.

Indian journal of dermatology , cilt.64, sa.3, ss.201-206, 2019 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

42. Oral health is a mediator for disease severity in patients with Behçet's disease: A multiple mediation analysis study.

Yay M., Celik Z., AKSOY A., Alibaz-Oner F., Inanc N., Ergun T., et al.

Journal of oral rehabilitation , cilt.46, sa.4, ss.349-354, 2019 (SCI-Expanded)

43. How Do We Assess the Clinical Parameters Related to Oral Health and the Patient Resources?

MUMCU G., KARAÇAYLI Ü., İNANÇ G. N., ERGUN S. A. T., ATALAY T., DİRESKENELİ R. H.

Turkiye Klinikleri Journal of Dental Sciences , cilt.26, sa.2, ss.268-275, 2019 (Hakemli Dergi)

44. Evaluation of salivary gland ultrasonography in primary Sjögren’xxs syndrome: does it reflect clinical activity and outcome of the disease?

İNANÇ G. N., ŞAHİNKAYA Y., MUMCU G., TÜREÖZDEMİR F., PAKSOY A., ERTÜRK Z., et al.

CLİNICAL EXPERIMENTAL RHEUMATOLOGY , cilt.37, ss.140-145, 2019 (SCI-Expanded)

45. IFN-γ stimulated dental follicle mesenchymal stem cells regulate activated lymphocyte response in rheumatoid arthritis patients in vitro

Zibandeh N., Genç D., Inanç G. N., Direskeneli R. H., Akkoç T.

Turkish Journal of Medical Sciences , cilt.49, sa.6, ss.1779-1788, 2019 (SCI-Expanded, Scopus, TRDizin)

46. Turkish Society for Rheumatology recommendations for the management of rheumatoid arthritis

ÇEFLE A., KESER G., TERZİOĞLU M. E., ERTENLİ A. İ., İNANÇ G. N., Coşan F., et al.

Ulusal Romatoloji Dergisi , cilt.10, sa.2, ss.81-84, 2018 (Hakemli Dergi)

47. The assessment of contributing factors to oral ulcer presence in Behçet's disease: Dietary and non-dietary factors.

Iris M., Ozcikmak E., AKSOY A., Alibaz-Oner F., Inanc N., Ergun T., et al.

European journal of rheumatology , cilt.5, sa.4, ss.240-243, 2018 (Hakemli Dergi)

48. Transient elastography with controlled attenuation parameter in the assessment of hepatic steatosis and significant liver fibrosis in patients with scleroderma

Yılmaz Y., Kani H. T., Şahinkaya Y., Deliktaş İ., Mursaloğlu H. H., Aziziy M., et al.

Hepatology International , cilt.12, 2018 (SCI-Expanded)

49. Oral ulcer activity in Behcet's disease: Poor medication adherence is an underestimated risk factor.

MUMCU G., Alibaz-Oner F., Oner S. Y., Ozen G., Atagunduz P., Inanc N., et al.

European journal of rheumatology , cilt.4, sa.2, ss.109-112, 2017 (TRDizin)

50. Which joints and why do rheumatologists scan in rheumatoid arthritis by ultrasonography? A real life experience.

Aydin S. Z., Pay S., Inanc N., Kamali S., Karadag O., Emery P., et al.

Clinical and experimental rheumatology , cilt.35, sa.3, ss.508-511, 2017 (SCI-Expanded)

51. Association of ERAP1, IL23R and PTGER4 Polymorphisms with Radiographic Severity of Ankylosing Spondylitis.

Ozen G., Deniz R., Eren F., Erzik C., Unal A., Yavuz S., et al.

The open rheumatology journal , cilt.11, ss.1-9, 2017 (Scopus)

52. The assessment of work productivity and activity impairment in Behcet's disease

MUMCU G., Lehimci F., Fidan O., Guk H., Alpar U., Unal A. U., et al.

TURKISH JOURNAL OF MEDICAL SCIENCES , cilt.47, sa.2, ss.535-541, 2017 (SCI-Expanded, Scopus, TRDizin)

53. Is ankle involvement underestimated in rheumatoid arthritis? Results of a multicenter ultrasound study

Gutierrez M., Pineda C., Salaffi F., Raffeiner B., Cazenave T., Martinez-Nava G. A., et al.

CLINICAL RHEUMATOLOGY , cilt.35, sa.11, ss.2669-2678, 2016 (SCI-Expanded)

54. Ultrasonographic Assessment of Fifth Metatarsophalangeal Joint Erosion in Rheumatoid Arthritis: Which Aspect Is Better?

Inanc N., Ozen G., Aydin S. Z., Kasapoglu-Gunal E., Direskeneli H.

Ultrasound in medicine & biology , cilt.42, sa.4, ss.864-9, 2016 (SCI-Expanded)

55. Certolizumab pegol for the treatment of rheumatoid arthritis

İNANÇ G. N.

RAED Dergisi , cilt.7, ss.1-7, 2015 (Hakemli Dergi)

56. Use of musculoskeletal ultrasound in rheumatoid arthritis in Turkey among rheumatologists: A national targeted ultrasound initiative survey

Cakilili O. T., Pay S., Inanc N., Kamali S., KARADAĞ Ö., KALYONCU U., et al.

EUROPEAN JOURNAL OF RHEUMATOLOGY , cilt.2, sa.1, ss.43-44, 2015 (ESCI)

57. A new Mucocutaneous Activity Index for Behçet's disease.

MUMCU G., Inanc N., Taze A., Ergun T., DİRESKENELİ R. H.

Clinical and experimental rheumatology , cilt.32, sa.4 Suppl 84, 2014 (SCI-Expanded)

58. Ankylosing spondylitis and a diagnostic dilemma: coccydynia

Deniz R., Ozen G., Yilmaz-Oner S., Aydin S. Z., Erzik C., Gunduz O. H., et al.

CLINICAL AND EXPERIMENTAL RHEUMATOLOGY , cilt.32, sa.2, ss.194-198, 2014 (SCI-Expanded)

59. Effects of azithromycin on intracellular cytokine responses and mucocutaneous manifestations in Behçet's disease.

MUMCU G., Inanc N., Ozdemir F. T., Tulunay A., Eksioglu-Demiralp E., Ergun T., et al.

International journal of dermatology , cilt.52, sa.12, ss.1561-6, 2013 (SCI-Expanded, Scopus)

60. Immunoglobulin subtypes predict therapy response to the biologics in patients with rheumatoid arthritis

Can M., Najip A., Yilmaz N., Inanc N., Yavuz S.

RHEUMATOLOGY INTERNATIONAL , cilt.33, sa.6, ss.1455-1460, 2013 (SCI-Expanded)

61. Lack of association between IL-6 gene polymorphisms and rheumatoid arthritis in Turkish population

Arman A., Coker A., Sarioz O., Inanc N., Direskeneli H.

RHEUMATOLOGY INTERNATIONAL , cilt.32, sa.7, ss.2199-2201, 2012 (SCI-Expanded)

62. Dysexecutive Syndrome: A Specific Pattern of Cognitive Impairment in Systemic Sclerosis

Yilmaz N., Mollahasanoglu A., Gurvit H., Can M., Tuncer N., Inanc N., et al.

COGNITIVE AND BEHAVIORAL NEUROLOGY , cilt.25, sa.2, ss.57-62, 2012 (SCI-Expanded)

63. No association of PTPN22 gene polymorphism with rheumatoid arthritis in Turkey

Sahin N., GÜNDÜZ F., Inanc N., DİRESKENELİ R. H., Saruhan-Direskeneli G.

RHEUMATOLOGY INTERNATIONAL , cilt.30, sa.1, ss.81-83, 2009 (SCI-Expanded, Scopus)

64. Association of salivary S. mutans colonisation and mannose-binding lectin deficiency with gender in Behcet's disease

MUMCU G., İNANÇ G. N., AYDIN S. Z., ERGUN S. A. T., DİRESKENELİ R. H.

CLINICAL AND EXPERIMENTAL RHEUMATOLOGY , cilt.27, sa.2, 2009 (SCI-Expanded, Scopus)

65. Assessment of Minimal Clinically Important Improvement By Using Oral Health Impact Profile 14 in Behcet s Disease

HAYRAN O. E., MUMCU G., İNANÇ G. N., ERGUN S. A. T., DİRESKENELİ R. H.

Clinical experimental rheumatology , cilt.27, ss.79-84, 2009 (SCI-Expanded)

66. Mannose binding lectin levels in spondyloarthropathies

Aydin S. Z., Atagunduz P., Inanc N., Bicakcigil M., Tasan D., Temel M., et al.

JOURNAL OF RHEUMATOLOGY , cilt.34, sa.10, ss.2075-2077, 2007 (SCI-Expanded)

67. The role of infectious agents in the pathogenesis, clinical manifestations and treatment strategies in Behçet's disease.

MUMCU G., Inanc N., Yavuz S., DİRESKENELİ R. H.

Clinical and experimental rheumatology , cilt.25, sa.4 Suppl 45, 2007 (SCI-Expanded, Scopus)

68. The Role of Infectious Agents in the Pathogenesis Clinical Manifestations and Treatment Strategies in Behcet s Disease Review

MUMCU G., İNANÇ G. N., YAVUZ Ş., DİRESKENELİ R. H.

Clin Exp Rheumatol , cilt.54, ss.27-33, 2007 (SCI-Expanded)

69. Anti-CCP antibodies in rheumatoid arthritis and psoriatic arthritis

Inanc N., Dalkilic E., Kamali S., Kasapoglu-Gunal E., Elbir Y., DİRESKENELİ R. H., et al.

CLINICAL RHEUMATOLOGY , cilt.26, sa.1, ss.17-23, 2007 (SCI-Expanded, Scopus)

70. Serum mannose-binding lectin levels are decreased in Behcet's disease and associated with disease severity

İNANÇ G. N., MUMCU G., BİRTAŞ E., Elbir Y., YAVUZ Ş., ERGUN S. A. T., et al.

JOURNAL OF RHEUMATOLOGY , cilt.32, sa.2, ss.287-291, 2005 (SCI-Expanded, Scopus)

71. [Primary health care].

Bedük T., Inanç N.

Turk hemsireler dergisi , cilt.33, sa.4, ss.26-7, 1983 (Scopus)

Hakemli Bilimsel Toplantılarda Yayımlanmış Bildiriler 69

1. Patients with Oral Ulcers Display High Levels of Salivary Acidic Glycoproteins in Behçet’s Syndrome

ÇEVİK ARAS H., POLAT AKMANSOY B., SARI F. B., AKMANSOY Ş. C., TATLI İ., ALİBAZ ÖNER F., et al.

The Joint Meeting of The European Association of Oral Medicine Region V, İstanbul, Türkiye, 25 Ekim 2024, ss.40, (Özet Bildiri)

2. Associations among Clinical Manifestations, Patient Empowerment, Patient Engagement, Patient Activation and in Primary Sjögren's Syndrome

SEVİMLİ E., POLAT AKMANSOY B., GÜNAY S., ALIYEVA A., SARI F. B., ŞİŞMAN KİTAPÇI N., et al.

The Joint Meeting of The European Association of Oral Medicine Region V, İstanbul, Türkiye, 25 - 27 Ekim 2024, (Özet Bildiri)

3. Identifying Low Disease Activity and Its Related Factors in Behçet's Syndrome through K-Means Cluster Analysis and Correspondence Analysis

POLAT AKMANSOY B., AKSOY B., ÇANDERELİ Z. Ö., SACOOR S., GOKANİ B., ALİBAZ ÖNER F., et al.

The Joint Meeting of The European Association of Oral Medicine Region V, İstanbul, Türkiye, 25 - 27 Ekim 2024, (Özet Bildiri)

4. THE EVALUATION OF LUNG CT DENSITOMETRY IN INTERSTITIAL LUNG DISEASES

ŞENGÜL Y., KOCAKAYA D., ILGIN C., ERYÜKSEL S. E., İNANÇ G. N., ÇİMŞİT N. Ç., et al.

European Congress of Radiology ECR 2020, Vienna, Avusturya, 15 - 19 Temmuz 2020, (Tam Metin Bildiri)

5. Kronik pulmoner tromboemboli nedeni ile izlenenolgularda endarterektomi sonrası saptanan izolepulmoner vaskülit: Vaka serisi

GAZEL Ü., KOCAKAYA D., YALÇINKAYA Y., İNANÇ G. N., YILDIZELİ B., ALİBAZ ÖNER F., et al.

XX. Ulusal Romatoloji Kongresi, Antalya, Türkiye, 16 - 20 Ekim 2019, cilt.11, ss.1-252, (Özet Bildiri)

6. Gelişmiş RA tedavisi almakta olup başka bir gelişmiş RA tedavisine geçen veya gelişmiş RA tedavisi-naif hastaların temel özellikleri ve tedavi yöntemi tercihlerinin ara analizi: Çok Merkezli, prospektif, gözlemsel çalışma

DİRESKENELİ R. H., KARADAĞ Ö., ATEŞ A., TUFAN A., İNANÇ G. N., KOCA S. S., et al.

20. uLUSAL ROMATOLOJİ KONGRESİ, Antalya, Türkiye, 16 - 20 Ekim 2019, (Tam Metin Bildiri)

7. ISOLATED PULMONARY VASCULITIS DIAGNOSEDHISTOPATHOLOGICALLY AFTER PULMONARYENDARTERECTOMY: A CASE SERIES

gazel u., kocakaya D., salçınkaya y., İNANÇ G. N., YILDIZELİ B., ALİBAZ ÖNER F., et al.

RHEUMATOLOGY 2019, atlanta, Amerika Birleşik Devletleri, 3 - 06 Mart 2019, cilt.58, (Tam Metin Bildiri)

8. Impact of Obesity on Drug Survival of Tofacitinib in Patients with Rheumatoid Arthritis: Analysis from Turkbio Registry

BABAOĞLU H., GÖKER B., İNANÇ G. N., BİRLİK A. M., KOCA S. S., CEFLE A., et al.

ACR/ARHP Annual Meeting, Chicago, USA, 2018., CHICAGO, Amerika Birleşik Devletleri, 19 - 24 Ekim 2018, (Özet Bildiri) Sürdürülebilir Kalkınma

9. Impact of Obesity on Drug Survival of Tofacitinib in Patients with Rheumatoid Arthritis: Analysis from the Turkbio Registry

BABAOĞLU H., GÖKER B., İNANÇ G. N., BİRLİK A. M., KOCA S. S., ÇEFLE A., et al.

American College of Rheumatology Congress’xx18, chicago, Amerika Birleşik Devletleri, 19 - 24 Ekim 2018, (Tam Metin Bildiri) Sürdürülebilir Kalkınma

10. İleri glikasyon son ürünleri: Psoriasis ve kardiyovasküler hastalık arasında olası bir bağlantı

ERGUN S. A. T., YAZICI V., YAVUZ D., SEÇKİN GENÇOSMANOĞLU D., ÖZEN G., SALMAN A., et al.

27. Ulusal Dermatoloji Kongresi, Türkiye, 16 - 20 Ekim 2018 Sürdürülebilir Kalkınma

11. Interim Analysis of Baseline Characteristics and Preferencesof Administration Route of Rheumatoid Arthritis PatientsWho Are Bio-Naïve or Switched between Advanced RATreatments A Multicenter, Prospective, ObservationalStudy

DİRESKENELİ R. H., KARADAĞ Ö., ATEŞ A., TUFAN A., İNANÇ G. N., KOCA S. S., et al.

2018 ACR/ARHP Annual Meeting, CHICAGO, Amerika Birleşik Devletleri, 19 - 24 Ekim 2018, cilt.70, (Tam Metin Bildiri)

12. Interim Analysis of Baseline Characteristics and preferences of administration route of rheumatoid arthritis patients who are bio-naive or switched between advanced RA treatments A multicenter, prospective, observational study

DİRESKENELİ R. H., KARADAĞ Ö., ATEŞ A., TUFAN A., İNANÇ G. N., KOCA S. S., et al.

2018 ACR/ARHP Annual Meeting, Şikago, Amerika Birleşik Devletleri, 19 - 24 Ekim 2018, cilt.70, (Tam Metin Bildiri)

13. PULMONER ARTERİTLER PULMONER ENDARTEREKTOMİ İÇİN RİSK FAKTÖRÜ MÜDÜR

DURUSOY A. F., İNANÇ G. N., OLGUN YILDIZELİ Ş., MUTLU B., taş s., YILDIZELİ B.

Türkiye Solunum Araştırmaları Derneği 40.ulusal kongresi, Antalya, Türkiye, 13 - 16 Ekim 2018, (Tam Metin Bildiri)

14. Ankilozan spondilitte hastal›k aktivitesi ve tedaviseçiminde yafl›n etkisi: TÜRK-B‹O veritaban›

Uslu S., Can G., Dalklç E., Şenel S., AKAR S., İNANÇ G. N., et al.

XIX. Ulusal Romatoloji Kongresi, Bodrum, Türkiye, 26 - 30 Eylül 2018, (Tam Metin Bildiri)

15. The efficacy and drug survival of the biosimilar infliximab (CT-P13) compared to the original reference infliximab in inflammatory rheumatic diseases results from the turkbio registry

USLU S., CAN G., ŞENEL S., DALKILIÇ H. E., İNANÇ G. N., AKAR S., et al.

EULAR2018, 13 - 16 Haziran 2018, (Özet Bildiri)

16. The effect of smoking on response to tumor necrosis factor-alpha inhibitor treatment in ankylosing spondylitis patients: results from the turkbio registry

YARKAN H., CAN G., ÇAPAR S., ZENGİN B., KENAR G., AKAR S., et al.

EULAR2018, 13 - 16 Haziran 2018, (Özet Bildiri)

17. The effect of smoking on response to tumor necrosis factor-alpha inhibitor treatment in ankylosing spondylitis patients: Results from the TURKBİO Registry.

TUĞSAL H. Y., CAN G., ÇAPAR S., ZENGİN B., KENAR G., AKAR S., et al.

EULAR 2018, Amsterdam, Hollanda, 13 - 16 Haziran 2018, cilt.77, ss.953, (Tam Metin Bildiri)

18. Concomitant use of corticosteroids at the baseline does not affect the drug survival of abatacept in rheumatoid arthritis.

KOCA S. S., ÖZ B. M., KARATAŞ A., DALKILIÇ H. E., CAN G., PEHLİVAN Y., et al.

EULAR 2018, Amsterdam, Hollanda, 13 - 16 Haziran 2018, cilt.77, ss.597, (Tam Metin Bildiri)

19. Comparision of long term anti_TNF survival in patients with ankylosing spondylitis and non-radiographic axial sponyloarthritis Data from TURKBİO Registry.

CAN G., DALKILIÇ H. E., PEHLİVAN Y., ŞENEL S., AKAR S., SOLMAZ D., et al.

EULAR 2018, Amsterdam, Hollanda, 13 - 16 Haziran 2018, cilt.77, ss.1545, (Tam Metin Bildiri)

20. Is there any difference in RA patients for methotrexate use vs leflunomide use as a concomitant treatment with biological and targeted synthetic DMARDS in TURKBİO Registry?

İNANÇ G. N., ÖZEN G., YALÇINKAYA Y., DALKILIÇ H. E., KOCA S. S., CAN G., et al.

EULAR 2018, Amsterdam, Hollanda, 13 - 16 Haziran 2018, cilt.77, ss.611, (Tam Metin Bildiri)

21. Romatoid Artrit Hastalarında Geriatrik Sendromların Sorgulanması: Geriatri-Romatoloji İşbirliği

TUFAN A., ERTÜRK Z., İNANÇ G. N., DİRESKENELİ R. H.

11.AKADEMİK GERİATRİ KONGRESİ, Antalya, Türkiye, 19 - 23 Nisan 2018, (Tam Metin Bildiri)

22. Ultrsonographic scoring of the major salivary glands: Is there a relationship with disease activity and functional status of glands

İNANÇ G. N., YALÇINKAYA Y., DİRESKENELİ R. H., ATAGÜNDÜZ M. P., Ertürk Z., MUMCU G., et al.

XVII Mediterranean Congress of Rheumatology, Genoa, İtalya, 12 - 14 Nisan 2018, cilt.36, ss.51, (Tam Metin Bildiri)

23. RHEUMATOID NODULE: PULMONARY NECROTIC-FIBROTIC NODULES IN PATIENTS WITH RHEUMATOID ARTHRITIS

BOZKURTLAR E., OLGUN YILDIZELİ Ş., AKSOY A., İNANÇ G. N.

7th INTERNATIONAL TRAKYA FAMILY MEDICINE CONGRESS, 21 - 25 Mart 2018, (Tam Metin Bildiri)

24. Transient elastography with controlled attenuation parameterin the assessment of hepatic steatosis and significant liver fibrosisin patients with scleroderma

Yılmaz Y., Kani H. T., Şahinkaya Y., Mursaloğlu H. H., Aziziy M., İnanç G. N., et al.

27th Annual Conference of APASL, Dilli, Hindistan, 14 - 18 Mart 2018, cilt.12, ss.378, (Özet Bildiri)

25. The association between two non-invasive methods for the assessment of severity of gastrointestinal involvement and malnutrition in systemic sclerosis: self-reported questionnaires and capillaroscopy

YALÇINKAYA Y., Ertürk Z., Pehlivan Ö., ÜNAL A. U., Kaymaz Tahra S., ATAGÜNDÜZ M. P., et al.

5TH systemic sclerosis world congress, Bordo, Fransa, 15 - 17 Şubat 2018, cilt.3, ss.210-211, (Tam Metin Bildiri) Sürdürülebilir Kalkınma

26. Is There Any Difference in RA Patients for Methotrexate Use Vs. Leflunomide Use As a Concomitant Treatment with Biological and Targeted Synthetic Dmards in Turkbio Registry

İNANÇ G. N., ÖZEN G., YALÇINKAYA Y., DALKILIÇ H. E., KOCA S. S., CAN G., et al.

ARTHRITIS RHEUMATOLOGY, 3 - 08 Kasım 2017, cilt.69, (Tam Metin Bildiri)

27. Body Mass Index Does Not Affect Response to Rituximab in Patients with Rheumatoid Arthritis: Results from Turkbio Registry

KOCA S. S., KARATAŞ A., ÖZ B., DALKILIÇ H. E., CAN G., PEHLİVAN Y., et al.

ARTHRITIS RHEUMATOLOGY, 3 - 08 Kasım 2017, cilt.69, (Tam Metin Bildiri)

28. Comparison of Long Term Anti-Tnf Survival in Patients with Ankylosing Spondylitis and Non-Radiographic Axial Spondyloarthritis Data from Turkbio Registry.

CAN G., DALKILIÇ H. E., PEHLİVAN Y., ŞENEL S., AKAR S., SOLMAZ D., et al.

ACR/ARHP 2017, San Diego, Amerika Birleşik Devletleri, 3 - 08 Kasım 2017, cilt.69, ss.1-4481, (Tam Metin Bildiri)

29. Is There Any Difference in RA Patients for Methotrexate Use Vs. Leflunomide Use As a Concomitant Treatment with Biological and Targeted Synthetic Dmard in Turkbio Registry ?

İNANÇ G. N., ÖZEN G. E., yalçınkaya y., DALKILIÇ H. E., KOCA S. S., gerçek c., et al.

Arthritis Rheumatology, 3 - 08 Kasım 2017, (Tam Metin Bildiri)

30. The Association between two non-invasive methods for the assessment of severity of gastrointestinal involvement and malnutrition in systemic sclerosis: self-reported questionnaires and nail fold video-capillaroscopy

yalçınkaya y., ertürk z., pehlivan ö., ünal a. u., ATAGÜNDÜZ M. P., DİRESKENELİ R. H., et al.

2017 ACR/ARHP Annual Meeting, 3 - 08 Kasım 2017, (Özet Bildiri) Sürdürülebilir Kalkınma

31. Erişkin Ailesel Akdeniz Ateşi hastalarında psöriasis sıklığı artmış mıdır?

AKSOY A., ÖZGEN Z., GAZEL Ü., İNANÇ G. N., ATAGÜNDÜZ M. P., ERGUN S. A. T., et al.

18. Ulusal Romatoloji Kongresi, Türkiye, 18 - 22 Ekim 2017, (Özet Bildiri)

32. Seronegatif romatoid artritli hastaların ultrasonografiile entezopati açısından değerlendirilmesi

Ertürk Z., ÖZSOY T., YAĞCI İ., GAZEL Ü., Yalçınkaya Y., ATAGÜNDÜZ M. P., et al.

18. Ulusal Romatoloji Kongresi, Türkiye, 18 - 22 Ekim 2017, cilt.9, ss.1-176, (Özet Bildiri)

33. Intoduction to enthesistis in ultrasonography

İNANÇ G. N.

Intermediate Ultrasound Course in Rheumatology Antalya, Turkey, 28 - 30 Eylül 2017

34. ILLNESS PERCEPTION IN PATIENTS WITH BEHCET DISEASE EMOTIONAL REACTIONS TO DISEASE SYMPTOMS

ERGUN S. A. T., İNANÇ G. N., DİRESKENELİ R. H., MUMCU G.

17th International Conference on Behçet's Disease, 15 - 17 Eylül 2017, cilt.34, (Özet Bildiri)

35. ASSESSING ENTHESITIS BY ULTRASONOGRAPHY IN PATIENTS WITH SERONEGATIVE RA

ertürk z., özsoy t., YAĞCI İ., yalçınkaya y., GAZEL Ü., ATAGÜNDÜZ M. P., et al.

EULAR 2017, 14 - 17 Haziran 2017, (Özet Bildiri)

36. ULTRASONOGRAPHİC SCORING OF THE MAJOR SALIVARY GLANDS IN SJOGREN SYNDROME: A COMPARATIVE STUDY WITH DISEASE ACTIVITY INDEXES

İNANÇ G. N., yalçınkaya y., MUMCU G., ERTÜRK Z., ÜNAL A. U., ATAGÜNDÜZ M. P., et al.

EULAR 2017, 14 - 17 Haziran 2017, (Özet Bildiri)

37. ULTRASONOGRAPHIC SCORING OF THE MAJOR SALIVARY GLANDS IN SJOGREN SYNDROME:A COMPATRATIVE STUDY WITH DISEASE ACTIVITY INDEXES

İNANÇ G. N., yalçınkaya y., MUMCU G., ERTÜRK Z., ÜNAL A. U., ATAGÜNDÜZ M. P., et al.

37THANNUAL SCIENTIFIC MEETING AND THE 11TH INTERNATIONAL SYMPOSIUM, 19 - 20 Mayıs 2017, (Tam Metin Bildiri)

38. Artefacts and Pitfalls

İNANÇ G. N.

Basic Ultrasound Course in Belek Antalya, Turkey, 27 - 29 Nisan 2017

39. 166EARLY RESULTS OF PATIENTS WITH ANTIPHOSPHOLIPID SYNDROME AND SYSTEMIC LUPUS ERYTHEMATOSUS FOLLOWING PULMONARY ENDARTERECTOMY

OLGUN YILDIZELİ Ş., İNANÇ G. N., MUTLU B., ŞAHİNKAYA Y., YANARTAŞ M., TAŞ S., et al.

12TH INTERNATIONAL CONGRESS ON SLE 7TH ASIAN CONGRESS ON AUTOIMMUNITY, 26 - 29 Mart 2017, (Özet Bildiri)

40. Association Between High Sodium Intake and Subclinical Atherosclerosis in Patients with Rheumatoid Arthritis

ÖZEN G., ÜNAL A. U., SAYDAM S., SÜNBÜL M., TİGEN M. K., DİRESKENELİ R. H., et al.

ACR 2016, 11 - 16 Kasım 2016, (Özet Bildiri)

41. Disease Severity and High Attack Frequency Under Colchicine Treatment Is Associated with Increased Carotid Intima Media Thickness in FMF

KARABACAK M., ÜNAL A. U., ÖZEN G., ERTÜRK Z., YALÇINKAYA Y., KOMESLİ Z., et al.

ACR 2016, 11 - 16 Kasım 2016, (Özet Bildiri)

42. Boolean Based Remission in Rheumatoid Arthritis Using Physician Versus Patient Global Assessment Differences in Ultrasonographic Disease Activities Sustainabilities and Relapse Rates

ÖZEN G., ÜNAL A. U., DİRESKENELİ R. H., İNANÇ G. N.

ACR 2016, 11 - 16 Kasım 2016, (Özet Bildiri)

43. ROMATOİD ARTRİT HASTALARINDA GERİATRİK SENDROMLARIN SORGULANMASI:GERİATRİ-ROMATOLOJİ İŞBİRLİĞİ

TUFAN A., ERTÜRK Z., İNANÇ G. N., DİRESKENELİ R. H.

18.ULUSAL ROMATOLOJİ KONGRESİ, Türkiye, 24 - 30 Ekim 2016, cilt.8, ss.1-161, (Özet Bildiri)

44. Introduction to enthesitis

İNANÇ G. N.

Eular Endorsed Intermediate Ultrasonography Course, 24 - 26 Ekim 2016

45. Early outcomes of patients with systemic lupus erythematosus and antiphospholipid syndrome after pulmonary endarterectomy

EVMAN S., OLGUN S., İNANÇ G. N., MUTLU B., YANARTAŞ M., YILDIZELİ B.

European Respiratory CONGRESS, 3 - 07 Ekim 2016, (Özet Bildiri)

46. Early Outcomes of Patients with Behc et s Disease Antiphospholipid syndrome and Systemic Lupus Erythematosus Following Pulmonary Endarterectomy

OLGUN YILDIZELİ Ş., İNANÇ G. N., MUTLU B., TAS B., YANARLAR M., ŞAHİNKAYA Y., et al.

15th International Congress on Antiphospholipid Antibodies, 21 - 24 Eylül 2016, (Özet Bildiri)

47. ORAL HEALTH RELATED OUTCOME MEASURES MUCOCUTANEOUS INDEX AND OHIP 14 CORRELATE WELL WITH THE CLINICAL ASSESSMENT OF ORAL ULCERS IN BD

ERGUN S. A. T., İNANÇ G. N., DİRESKENELİ R. H., MUMCU G.

17 th ınternational Conference on Behçet's Disease, 15 - 17 Eylül 2016, cilt.34, (Özet Bildiri)

48. THE ASSESSMENT OF WORK PRODUCTIVITY AND ACTIVITY IMPAIRMENT IN BEHCET S DISEASE

ERGUN S. A. T., İNANÇ G. N., DİRESKENELİ R. H., MUMCU G.

17 th International Conference on Behçet's Disease, 15 - 17 Eylül 2016, cilt.34, (Özet Bildiri)

49. LOW MEDICATION ADHERENCE IS ASSOCIATED WITH ORAL ULCER ACTIVITY AND QUALITY OF LIFE IN BEHCET S DISEASE

ERGUN S. A. T., İNANÇ G. N., DİRESKENELİ R. H., MUMCU G.

17 th International Conference on Behçet's Disease, 15 - 17 Eylül 2016, cilt.34, (Özet Bildiri)

50. ORAL HEALTH CAN BE IMPROVED BY ORAL HYGIENE EDUCATION IN BEHCET S DISEASE A LONG TERM FOLLOW UP STUDY

ERGUN S. A. T., İNANÇ G. N., DİRESKENELİ R. H., MUMCU G.

17 th International Conference on Behçet's Disease, 15 Eylül 2016, cilt.34, (Özet Bildiri)

51. The effect of cardiac rehabilitation program on disease activity functional outcome and cardiovascular risk in patients with rheumatoid arthritis

PEYNİRCİ CERŞİT H., YAĞCI İ., İNANÇ G. N., cerşit s.

eular, 01 Haziran 2016, (Özet Bildiri)

52. ROMATOİD ARTRİT GELİŞİMİ ÖNLENEBİLİR Mİ

İNANÇ G. N.

ANADOLU ROMATOLOJİ GÜNLERİ 2016, Türkiye, 11 - 15 Mayıs 2016

53. Artefacts and Pitfalls in Ultrasonography

İNANÇ G. N.

EULAR Endorsed Basic Ultrasound course, 28 - 30 Nisan 2016

54. SUBCLINICAL ATHEROSCLEROSIS AND ESTIMATION OF CARDIOVASCULAR RISK IN SYSTEMIC SCLEROSIS

ÖZEN G., KORKMAZ F., SÜNBÜL M., DENİZ R., TİGEN M. K., ATAGÜNDÜZ M. P., et al.

ANNUAL EUROPEAN CONGRESS OF RHEUMATOLOGY, 10 - 13 Mayıs 2015, (Özet Bildiri)

55. THE 2013 ACC AHA 10 YEAR ATHEROSCLEROTIC CARDIOVASCULAR DISEASE ASCVD RISK INDEX ISBETTER THAN SCORE AND QRISK II IN RHEUMATOID ARTHRITIS IS IT ENOUGH

ÖZEN G., SÜNBÜL M., ATAGÜNDÜZ M. P., DİRESKENELİ R. H., TİGEN M. K., İNANÇ G. N.

ANNUAL EUROPEAN CONGRESS OF RHEUMATOLOGY, 10 - 13 Mayıs 2015, (Özet Bildiri) Sürdürülebilir Kalkınma

59. The Value of the 2010 ACR Eular Rheumatoid Arthritis Classification Criteria for the Prognosis of Early Arthritis Evaluation of Erosion Development with Ultrasonography

İNANÇ G. N., ALİBAZ ÖNER F., CAN M., DİRESKENELİ R. H.

Annual European Congress of Rheumatology EULAR, 2013, 12 - 15 Haziran 2013, cilt.72, ss.753

63. Romatoid artritli hastalarda artmis yorgunluk hemhastalik aktivitesi ve fonksiyonel kayip hem de mentaldurum ile iliskilidir

İLHAN B., CAN M., ALİBAZ ÖNER F., ÖNER S., İNANÇ G. N., DİRESKENELİ R. H.

13.Ulusal Romatoloji Kongresi, Türkiye, 13 - 17 Ekim 2012, cilt.4, ss.125-126

64. Behçet hastalarInda yorgunluk artmis veyasam kalitesi düsmüstür

İLHAN B., CAN M., ALİBAZ ÖNER F., ÖNER S., İNANÇ G. N., ERGUN S. A. T., et al.

13.Ulusal Romatoloji Kongresi, Türkiye, 13 Ekim 2012, cilt.4, ss.157

65. Erken artritli hastalarda 2010 ACR EULAR romatoidartrit siniflandirma kriterlerinin tani ve prognozdakidegeri

ALİBAZ ÖNER F., ATAGÜNDÜZ M. P., DİRESKENELİ R. H., İNANÇ G. N.

13.Ulusal Romatoloji Kongresi, Türkiye, 13 - 17 Ekim 2012, cilt.4, ss.73

66. Accelerated infusion rates of RITUXIMAB is well tolerated and safe in rheumatology practice A single center experience

CAN M., ALİBAZ ÖNER F., ÖNER S., ATAGÜNDÜZ M. P., İNANÇ G. N., DİRESKENELİ R. H.

Annual European Congress of Rheumatology EULAR, 2012, 6 - 09 Haziran 2012, cilt.71, ss.670, (Özet Bildiri)

Metrikler

Yayın

140

Yayın (WoS)

Yayın (Scopus)

Atıf (WoS)

446

H-İndeks (WoS)

Atıf (Scopus)

707

H-İndeks (Scopus)

Atıf (Scholar)

H-İndeks (Scholar)

Atıf (TrDizin)

H-İndeks (TrDizin)

Atıf (Diğer Toplam)

Tez Danışmanlığı

Açık Erişim

BM Sürdürülebilir Kalkınma Amaçları

Yayınlar & Eserler

Yayın

Yayın (WoS)

Yayın (Scopus)

Atıf (WoS)

H-İndeks (WoS)

Atıf (Scopus)

H-İndeks (Scopus)

Atıf (Scholar)